Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Dec 1;49(12):e1265-e1266.
doi: 10.1097/CCM.0000000000005238.

Influenza-Associated Pulmonary Aspergillosis: Seek, and You Shall Find!

Simon R L Feys  1 , Shmuel Shoham  2 , Bart J A Rijnders  3   4 , Joost Wauters  1
Affiliations
Comment

Influenza-Associated Pulmonary Aspergillosis: Seek, and You Shall Find!

Simon R L Feys et al. Crit Care Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Shoham reports grants from Ansun, personal fees from Amplyx, grants from Astellas, personal fees from Acidophil, grants from Cidara, grants from F2G, personal fees from Jannssen, grants from Merck, grants from T2, personal fees from Reviral, grants from Shire, grants from Shionogi, grants from Gilead, personal fees from Intermountain Health, personal fees from Karyopharm, personal fees from Immunome, personal fees from Celltrion, outside the submitted work. Dr. Wauters reports investigator-initiated grants and speakers’ fees from MSD, Gilead, and Pfizer, outside the submitted work. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Comment in

  • The authors reply.
    Coste A, Aubron C. Coste A, et al. Crit Care Med. 2021 Dec 1;49(12):e1267-e1268. doi: 10.1097/CCM.0000000000005340. Crit Care Med. 2021. PMID: 34793395 No abstract available.

Comment on

References

    1. Coste A, Frérou A, Raute A, et al. The extent of aspergillosis in critically ill patients with severe influenza pneumonia: A multicenter cohort study. Crit Care Med. 2021; 49:934–942
    1. Martin-Loeches I, J Schultz M, Vincent JL, et al. Increased incidence of co-infection in critically ill patients with influenza. Intensive Care Med. 2017; 43:48–58
    1. Verweij P, Rijnders B, Brüggemann R, et al. International expert review of influenza-associated pulmonary aspergillosis in ICU patients and recommendations for a case definition. Intensive Care Med. 2020; 46:1524–1535
    1. Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: A tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med. 2008; 177:27–34
    1. Vanderbeke L, Janssen NAF, Bergmans DCJJ, et al.; Dutch-Belgian Mycosis Study Group: Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): A randomised, open-label, proof-of-concept trial. Intensive Care Med. 2021; 47:674–686

MeSH terms